Do I need to take Ozempic and metformin at different times of day?

The Ozempic label does not call for separating the two. It says no dose adjustment is required for the oral medicines tested with semaglutide, and metformin was one of them. Take each one as your prescription says.

Can I stop metformin once I start Ozempic?

Do not stop it on your own. In most Ozempic label trials, people stayed on metformin while they took Ozempic. Your prescriber decides whether you still need both.

Will I lose more weight on Ozempic and metformin than on Ozempic alone?

The label trials cannot answer that. They enrolled people already on metformin and did not include a group on Ozempic without it. In one 56-week trial on a metformin background, people lost 2.5 kg more on Ozempic 0.5 mg and 3.8 kg more on 1 mg than on sitagliptin.

Does taking both drugs raise the risk of vitamin B12 deficiency?

The B12 warning is on the metformin label. It reports below-normal B12 in about 7% of patients in 29-week trials and recommends a B12 check every 2 to 3 years. The Ozempic label does not list B12 deficiency.

Can You Take Ozempic and Metformin Together?

Q: What are the warning signs of lactic acidosis on metformin?

The metformin label says the start is often subtle. Symptoms include malaise, muscle pain, trouble breathing, sleepiness, and abdominal pain. The label treats suspected lactic acidosis as a hospital emergency.

The short answer: Yes. Many people with type 2 diabetes take both, and the FDA label says Ozempic was studied in combination with metformin. A drug interaction study on the label found no clinically relevant interaction, and no dose adjustment is required. The two things to watch are stomach side effects, which both drugs cause, and dehydration, which matters for your kidneys.

Is it safe to take Ozempic and metformin together?

The FDA-approved Ozempic label does not warn against metformin. It says Ozempic "has been studied as monotherapy and in combination with metformin, metformin and sulfonylureas, metformin and/or thiazolidinedione, and basal insulin."

The label does raise one general point about pills. Ozempic slows stomach emptying, so it "has the potential to impact the absorption" of medicines taken by mouth. The maker tested this with several oral drugs, including metformin at steady state. The label reports that "no clinically relevant drug-drug interaction with semaglutide" was observed, and that "no dose adjustment is required" for those medicines.

The label still tells prescribers to use caution when oral medicines are taken with Ozempic. That is a general statement about all pills. It is not a warning specific to metformin.

The MedlinePlus page on semaglutide injection says to tell your doctor and pharmacist about every medicine you take. Your doctor "may need to change the doses of your medications or monitor you carefully for side effects."

What did the trials of Ozempic with metformin show?

Most of the blood sugar trials on the Ozempic label enrolled people who already took metformin. The label describes four of them:

Ozempic compared with sitagliptin. A 56-week trial randomized 1,231 adults. All took metformin (94%), a thiazolidinedione (6%), or both. HbA1c started near 8%. It fell by 1.3 points on Ozempic 0.5 mg, 1.5 points on 1 mg, and 0.7 points on sitagliptin.
Ozempic compared with exenatide extended-release. A 56-week trial enrolled 813 adults. About half (49%) took metformin alone.
Ozempic compared with insulin glargine. A 30-week trial enrolled 1,089 adults on metformin (48%) or metformin with a sulfonylurea (51%).
Ozempic 2 mg compared with 1 mg. A 40-week trial enrolled 961 adults on metformin, with or without a sulfonylurea. HbA1c fell by 2.1 points on 2 mg and 1.9 points on 1 mg. The label says no new safety signals were identified.

The first trial is published as SUSTAIN 2. Its authors concluded that semaglutide was superior to sitagliptin for blood sugar and body weight in people on metformin, thiazolidinediones, or both.

These trials have a limit. None of them compared Ozempic with metformin against Ozempic without metformin. They show that Ozempic works and is tolerated in people who already take metformin. They do not measure how much metformin adds.

Does the combination cause low blood sugar?

The label ties the low blood sugar risk to other drugs. Its warning covers people who take Ozempic with insulin or with an insulin secretagogue such as a sulfonylurea. Metformin is not named in that warning.

The label gives a reason. Ozempic "stimulates insulin release in the presence of elevated blood glucose concentrations." Its effect on insulin depends on blood sugar being high.

The numbers on the label show the difference:

Ozempic alone: no severe low blood sugar events in a 30-week trial.
Ozempic with a sulfonylurea: severe events in 0.8% of people on 0.5 mg and 1.2% on 1 mg. Documented symptomatic events occurred in 17.3% and 24.4%.

In SUSTAIN 2, where almost everyone took metformin, confirmed low blood sugar occurred in 2% of people on semaglutide 0.5 mg and fewer than 1% on 1 mg. The rate on sitagliptin was 1%.

The metformin label makes the same point about its own drug. It says metformin may increase the risk of low blood sugar "when combined with insulin and/or an insulin secretagogue." If you take a sulfonylurea or insulin as well, ask your prescriber what to watch for. MedlinePlus lists dizziness, sweating, hunger, and irritability among the signs.

Are stomach side effects worse when you take both?

Both drugs upset the stomach, so the effects can overlap. No trial on either label measured how much worse they are together.

Here are the rates each label reports for its own drug against placebo:

Ozempic: nausea in 15.8% on 0.5 mg and 20.3% on 1 mg, compared with 6.1% on placebo. Diarrhea in 8.5% and 8.8%, compared with 1.9%. Vomiting in 5% and 9.2%, compared with 2.3%.
Metformin extended-release: diarrhea in 10%, compared with 3% on placebo. Nausea or vomiting in 7%, compared with 2%.

These numbers come from different trials, so do not add them together. They show that nausea and diarrhea are common on each drug.

If stomach symptoms start after you add Ozempic, tell your prescriber. Do not stop or cut either medicine on your own. Our Ozempic nausea tips cover meal size and timing. Our sister site glp1.md covers the other drugs in this class.

Why do dehydration and kidney function matter on this combination?

This is the main safety point for people on both drugs. Each label has a kidney warning, and the two connect through dehydration.

The Ozempic label reports cases of acute kidney injury after approval, "in some cases requiring hemodialysis." Most occurred in people who had nausea, vomiting, or diarrhea that led to dehydration.

The metformin label carries a boxed warning for lactic acidosis, a rare and serious buildup of lactic acid in the blood. The label names kidney impairment as a risk factor. Its patient section adds dehydration, and says this can happen "if you are sick with a fever, vomiting, or diarrhea."

The metformin label sets kidney limits by eGFR, a blood test of kidney function:

Metformin is contraindicated when eGFR is below 30.
Starting metformin is not recommended when eGFR is between 30 and 45.
If eGFR later falls below 45, the label says to assess the benefit and risk of continuing.

The practical point: call your prescriber if you cannot keep fluids down. The metformin label describes the early symptoms of lactic acidosis as nonspecific. They include malaise, muscle pain, trouble breathing, sleepiness, and abdominal pain. Our guide to Ozempic and kidney problems covers the kidney data in more detail.

Why do doctors prescribe both?

Metformin usually comes first. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) says "most people with type 2 diabetes start with metformin pills." It also says that combining two or three kinds of diabetes medicine "can lower blood glucose levels better than taking just one medicine."

The two drugs work in different ways. The NIDDK says metformin helps the liver make less glucose and helps the body use insulin better. Ozempic raises insulin release when blood sugar is high and slows stomach emptying.

Ozempic also has approved uses that metformin does not. Its label covers lowering the risk of major cardiovascular events in adults with type 2 diabetes and established heart disease. It also covers lowering the risk of kidney function decline in adults with type 2 diabetes and chronic kidney disease. The metformin label says no clinical study has established conclusive evidence that metformin reduces macrovascular risk.

A 2022 consensus report from the American Diabetes Association and the European Association for the Study of Diabetes reflects this. It says heart and kidney outcome trials of GLP-1 drugs inform broader recommendations for people at high risk of heart or kidney disease.

One long-term point belongs to metformin. In 29-week trials on its label, vitamin B12 fell to below-normal levels in about 7% of patients. The label recommends a B12 check every 2 to 3 years. Our guide to Ozempic and B12 deficiency has more.

The bottom line

You can take Ozempic and metformin together. Most Ozempic label trials enrolled people on metformin, and the label found no clinically relevant interaction. The low blood sugar warning applies to insulin and sulfonylureas. Both drugs cause nausea and diarrhea, and dehydration from those symptoms can harm the kidneys and raise the risk of lactic acidosis on metformin. Call your prescriber if you cannot keep fluids down.

Last updated: October 2026. This article is for informational purposes only and does not constitute medical advice. Talk with your prescriber or pharmacist before you start, stop, or change the dose of Ozempic or metformin.